| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIAF | bioAffinity Technologies, Inc. | KNIGHT PETER S | Director | Oct 01, 2023 | Option Exercise | $1.58 | 11,867 | 18,750 | 62,707 | Jan 24, 2024, 08:52 PM | |
| BIAF | bioAffinity Technologies, Inc. | KNIGHT PETER S | Director | Jan 01, 2024 | Option Exercise | $1.48 | 12,668 | 18,749 | 75,375 | Jan 24, 2024, 08:52 PM | |
| BIAF | bioAffinity Technologies, Inc. | KNIGHT PETER S | Director | Jan 01, 2023 | Option Exercise | $2.28 | 8,227 | 18,758 | 30,675 | Jul 06, 2023, 04:15 PM | |
| BIAF | bioAffinity Technologies, Inc. | KNIGHT PETER S | Director | Apr 15, 2023 | Option Exercise | $1.89 | 9,920 | 18,749 | 40,595 | Jul 06, 2023, 04:15 PM | |
| BIAF | bioAffinity Technologies, Inc. | KNIGHT PETER S | Director | Jul 01, 2023 | Option Exercise | $1.83 | 10,245 | 18,748 | 50,840 | Jul 06, 2023, 04:15 PM | |
| MRX | MEDICIS PHARMACEUTICAL CORP | KNIGHT PETER S | Director | Dec 11, 2012 | Option Exercise | $44.00 | 12,532 | 551,408 | 0 | Dec 13, 2012, 04:20 PM | |
| PRX | PAR PHARMACEUTICAL COMPANIES, INC. | KNIGHT PETER S | Director | Sep 28, 2012 | Option Exercise | $50.00 | 3,500 | 175,000 | 0 | Oct 02, 2012, 06:05 PM | |
| MRX | MEDICIS PHARMACEUTICAL CORP | KNIGHT PETER S | Director | Aug 23, 2012 | Sale | $26.30 | 7,000 | 184,100 | 16,032 | Aug 27, 2012, 05:40 PM | |
| PRX | PAR PHARMACEUTICAL COMPANIES, INC. | KNIGHT PETER S | Director | Mar 19, 2012 | Sale | $32.91 | 15,000 | 493,600 | 11,000 | Mar 21, 2012, 05:55 PM | |
| PRX | PAR PHARMACEUTICAL COMPANIES, INC. | KNIGHT PETER S | Director | Dec 15, 2011 | Sale | $31.21 | 5,000 | 156,034 | 6,000 | Dec 19, 2011, 02:57 PM | |
| MRX | MEDICIS PHARMACEUTICAL CORP | KNIGHT PETER S | May 19, 2011 | Sale | $30.31 | 62,000 | 1,879,042 | 41,221 | May 23, 2011, 06:35 PM |
Menu